NCT04528901UnknownNot Applicable
Study of seroPREvalence Vis-à-vis SARS-CoV2 and Correlation With Clinical Forms of COVID-19 in Patients Followed in Pneumology in the Cluster Area of the Grand-Est Region (Strasbourg University Hospital)
University Hospital, Strasbourg, France1 site in 1 country1,080 target enrollmentStarted: September 4, 2020Last updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Sponsor
- Enrollment
- 1,080
- Locations
- 1
- Primary Endpoint
- Determine and compare the seroprevalence for SARS-CoV2 among patients with respiratory pathologies monitored in Pneumology at the Strasbourg University Hospital, in the cluster zone of the Grand Est.
Study Overview
Brief Summary
seroPREvalence vis-à-vis SARS-CoV2 and correlation with clinical forms of COVID-19 in patients followed in Pulmonology in the cluster area of the Grand-Est region.
Study Design
- Study Type
- Observational
- Observational Model
- Cohort
- Time Perspective
- Prospective
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Man or woman from 18 years old and without upper age limit
- •Patient followed in pulmonology at Strasbourg University Hospital
- •Patient presenting at least one of the following pathologies:
- •severe persistent asthma (200 patients)
- •chest cancer that is active or has received treatment within a period of less than one year (300 patients)
- •history of lung transplantation performed before the start of the epidemic (02/29/2020) (300 patients)
- •idiopathic or other diffuse interstitial lung disease, sarcoidosis or vasculitis (70 patients)
- •pulmonary arterial hypertension (PAH) (group 1 of the international classification) any cause or chronic thromboembolic PAH (group 4): (60 patients)
- •Severe COPD in the respiratory failure stage (150 patients)
- •Subject affiliated to a social health insurance protection scheme
- •Subject able to understand the objectives of the research
- •Subject having signed an informed consent
Exclusion Criteria
- •Inability to provide informed information about the subject (subject in an emergency situation, difficulty in understanding the subject, etc.)
- •Subject under safeguard of justice
- •Subject under guardianship or guardianship
Outcomes
Primary Outcomes
Determine and compare the seroprevalence for SARS-CoV2 among patients with respiratory pathologies monitored in Pneumology at the Strasbourg University Hospital, in the cluster zone of the Grand Est.
Time Frame: 15 months
Carrying out a serological assay of specific antibodies to SARS-CoV-2
Secondary Outcomes
No secondary outcomes reported
Investigators
Study Sites (1)
Loading locations...
Similar Trials
Completed
Not Applicable
COVID-19 in Rheumatic Inflammatory Diseases Under Immuno-suppressive DrugsChronic Inflammatory RheumatismNCT04530682University Hospital, Montpellier163
Completed
Not Applicable
Seroprevalence of SARS-Cov-2 in the Setting of a Non-dedicated COVID-19 Hospital in a Low CoV-2 Incidence Area: Implications for SurgeryCovid19SurgerySARS (Severe Acute Respiratory Syndrome)NCT04480580University of Cagliari100
Completed
Not Applicable
Seroprevalence of SARS-CoV-2 in Asymptomatic Frontline COVID-19 HCWsCovid19NCT04563247Lahore General Hospital970
Recruiting
Not Applicable
Seroprevalence of SARS CoV-2 infections/Covid-19 in blood donors and patients of the University Hospitals in LeipzigU07.1COVID-19, virus identifiedDRKS00023364Institut für Medizinische Mikrobiologie und Virologie, Universitätsklinikum Leipzig2,000
Completed
Not Applicable
Corona Immunitas: a nationwide program of antibody studies of SARS-CoV-2 in the Swiss populatioISRCTN18181860Swiss School of Public Health28,000